![Markku Tapani Jalkanen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markku Tapani Jalkanen
Directeur/Membre du Conseil chez
Faron Ventures Oy
Fortune : 857 117 $ au 31/08/2026
Profil
Markku Tapani Jalkanen founded Biotie Therapies Oy in 1992, where he worked as President & Chief Executive Officer from 1996 to 2002 and Faron Pharmaceuticals Oy in 2003, where he is working as Independent Non-Executive Director from 2024.
Dr. Jalkanen also currently works at Faron Ventures Oy, as Director and Inveni Capital Oy, as Partner & Advisor from 2014.
Dr. Jalkanen also formerly worked at Medeia Therapeutics Oy, as Chairman, Lx Therapies Oy, as Chairman, Priaxon AG, as Director, and the University of Turku, as Professor.
Dr. Jalkanen received his doctorate degree from the University of Turku and graduate degree from the University of Kuopio.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FARON PHARMACEUTICALS OY 0,71 % | 26/03/2026 | 1 625 266 ( 0,71 % ) | 857 117 $ | 31/08/2026 |
Postes actifs de Markku Tapani Jalkanen
| Sociétés | Poste | Début |
|---|---|---|
Inveni Capital Oy
 Inveni Capital Oy Investment ManagersFinance Inveni Capital invests in companies located in Northern and Central Europe primarily in Finland and Germany. The firm targets companies operating in pharmaceutical and medical technology sectors. It provides equity financing for early and growth stage transactions. | Private Equity Investor | 01/01/2014 |
Faron Ventures Oy | Directeur/Membre du Conseil | - |
Anciens postes connus de Markku Tapani Jalkanen
| Sociétés | Poste | Fin |
|---|---|---|
| BIOTIE THERAPIES CORP | Directeur Général | 01/01/2002 |
University of Turku
 University of Turku Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| FARON PHARMACEUTICALS OY | Fondateur | - |
Priaxon AG
 Priaxon AG Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery company for small molecule therapeutics | Directeur/Membre du Conseil | - |
Medeia Therapeutics Oy
 Medeia Therapeutics Oy Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which discovers and develops new therapeutic approaches for diseases with unmet medical needs | Président | - |
Formation de Markku Tapani Jalkanen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
University of Turku
University of Turku Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faron Pharmaceuticals Oy
 Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
University of Kuopio
 University of Kuopio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inveni Capital Oy
Inveni Capital Oy Investment ManagersFinance Inveni Capital invests in companies located in Northern and Central Europe primarily in Finland and Germany. The firm targets companies operating in pharmaceutical and medical technology sectors. It provides equity financing for early and growth stage transactions. | Finance |
Priaxon AG
Priaxon AG Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery company for small molecule therapeutics | Commercial Services |
Medeia Therapeutics Oy
Medeia Therapeutics Oy Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which discovers and develops new therapeutic approaches for diseases with unmet medical needs | Commercial Services |
Lx Therapies Oy
 Lx Therapies Oy Pharmaceuticals: MajorHealth Technology Provides drug discovery solutions for cancer treatment | Health Technology |
Faron Ventures Oy |
